Position in LLY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$749,643
+$174,787 QoQ
Shares Held
625
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#3,388
of 4,605 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HALL LAURIE J TRUSTEE holds $19,577,945 across 7 Drug Manufacturers - General names. LLY ranks #6 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
30,162 | $7,660,240 | |
| 2 | NVS |
Novartis AG
|
22,897 | $3,588,416 | |
| 3 | ABBV |
AbbVie Inc.
|
13,705 | $3,448,726 | |
| 4 | AMGN |
Amgen Inc
|
5,502 | $1,992,384 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,164 | $1,563,073 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
625 | $749,643 | |
| 7 | PFE |
Pfizer Inc
|
23,898 | $575,463 |
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $749,643 | 625 | Shares | Defined | 2026-07-09 | |
| 2026-03-31 | $574,856 | 625 | Shares | Defined | 2026-04-06 | |
| 2025-12-31 | $671,675 | 625 | Shares | Defined | 2026-01-20 | |
| 2025-09-30 | $534,100 | 700 | Shares | Defined | 2025-10-14 | |
| 2025-06-30 | $545,671 | 700 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $578,137 | 700 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $540,400 | 700 | Shares | Other | 2025-01-16 | |
| 2024-09-30 | $1,063,128 | 1,200 | Shares | Other | 2024-10-08 | |
| No filing history on record for this holder in this stock. | ||||||